Sign in Subscribe
Cancer

Targeting Macropinocytosis in Cancer Therapy Showcases Promising Approach to Personalized Medicine

Strategic Insights

— 1 min read

Researchers have made significant strides in understanding the role of macropinocytosis in cancer development and treatment, opening doors to innovative approaches in personalized medicine. A study published in the Journal of Controlled Release highlights the importance of modulating macropinocytosis in cancer therapy, offering new opportunities for effective and targeted treatments.

Key Takeaways:

  • Macropinocytosis, a cellular process, plays a crucial role in tumor survival and therapy, particularly in cancers with KRAS mutations or PTEN deficiencies.
  • Engineered therapeutics, including nanoparticles, peptide-drug conjugates, and macromolecule-bound drugs, leverage elevated macropinocytic activity in tumor cells for enhanced drug uptake and treatment efficacy.
  • The research emphasizes the need to address challenges in translating macropinocytosis-targeting therapies into clinical practice, including tumor heterogeneity and drug resistance.
  • The study highlights the potential of modulating macropinocytosis as a strategy for personalized cancer treatment.
  • Authors include Bo Kyung Cho, Hye-Ran Moon, Seung Hyun Kang, Ju Hee Ryu, and Ick Chan Kwon, with research conducted under the direction of the Biomedical Research Institute, Korea Institute of Science and Technology.

Statistics:

  • The study focuses on the molecular mechanisms regulating macropinocytosis in cancer, specifically addressing both intrinsic factors (e.g., oncogenic mutations) and extrinsic influences from the tumor microenvironment.
  • Researchers explored both inhibition strategies and therapeutic exploitation of macropinocytosis in cancer therapy, highlighting the need for more effective and personalized cancer treatments.
  • The study emphasized the importance of addressing tumor heterogeneity and drug resistance in translating macropinocytosis-targeting therapies into clinical practice.

Sources:

  • VerticalNews. (2023, June 30). New Research on Drugs and Therapies-Personalized Medicine. Retrieved from
  • Biomedical Research Institute. (2023). Targeting and Exploiting Macropinocytosis in Cancer Therapy. Journal of Controlled Release, 2025, 113962.
  • Cho, B. K., et al. (2023). Targeting and exploiting macropinocytosis in cancer therapy. Journal of Controlled Release, 2025, 113962.
  • NewsRx. (2023, June 30). Biomedical Research Institute Reports Findings in Personalized Medicine (Targeting and exploiting macropinocytosis in cancer therapy). Journal of Engineering, 173.

Read more